Physician profile
Daniel Cleary
NPI 1164833570
$62,986.33
in general payments reported to CMS, 2019-2025
11 companies · $7,801 in 2025
The $7,801 reported for 2025 was more than what 84% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.49 · 2020: $123 · 2022: $49K · 2023: $2,374 · 2024: $3,261 · 2025: $7,801.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,250 · Travel and Lodging: $4,593 · Food and Beverage: $3,580 · Entertainment: $14.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,250.00 |
| Travel and Lodging | $4,592.70 |
| Food and Beverage | $3,579.64 |
| Entertainment | $14.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $25,338.69 | 2022-2024 | |
| Medtronic, INC. | $20,638.88 | 2022-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim |
| Insightec,INC | $7,949.44 | 2022-2025 | Exablate |
| Biotronik Nro, INC. | $5,411.54 | 2025 | Prospera |
| Abbott Laboratories | $1,960.58 | 2023-2024 | Proclaim, Eterna |
| Alphatec Spine, INC | $1,176.30 | 2024 | Other - Miscellaneous |
| Saluda Medical Americas, INC. | $175.53 | 2024 | Evoke |
| Medtronic USA, INC. | $137.86 | 2019-2020 | |
| Brainlab, INC. | $95.01 | 2024 | Surgical Planning and Navigation Radiation Treatment Planning and Positioning |
| Biocomposites INC | $84.24 | 2025 | Stimulan |
| Globus Medical, INC. | $18.26 | 2025 | Creo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Cleary listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.